High‐Grade Atypia in Circulating Tumour‐Related Endothelial‐Like Cells Serves as a Specific Marker for Malignant Thoracic Tumours

Key Points

• The aim is to evaluate high-grade atypia in circulating tumour-related endothelial-like cells as a marker for malignant thoracic tumours.
• Clinical trials involving UMIN Clinical Trials Registry procedures.
• Assessment of circulating tumour-related endothelial-like cells for atypia.
• Analysis of high-grade atypia specificity in thoracic malignancies.
• High-grade atypia in endothelial-like cells is significantly associated with malignant thoracic tumours.
• Identifying this atypia improves differentiation between malignant and benign conditions.